Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Diabetes
Recent news which mentions Diabetes
< Previous
1
2
3
4
Next >
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Breaking news
Health care industry
Business News
From
CNBC.com News
Australian Influencer Thought She Was 'Going To Die' After Overdosing On 'Miracle' Weight Loss Drug Ozempic
September 04, 2023
Tags
Diabetes
weightloss
Benzinga
From
Benzinga
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Policy
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Erika Jayne Pushes Back Against Claims Of Taking Weight Loss Drug Ozempic: 'I've Always Been Tiny'
August 30, 2023
Tags
General
Ozempic
Media
From
Benzinga
Weight-Loss Drug Ozempic Sparks Frenzy In Cyprus Despite Limited Accessibility
August 27, 2023
Tags
Benzinga
Diabetes
weightloss
From
Benzinga
Kim Kardashian's Slim Waistline Sparks Speculation About Ozempic Use: 'What Waist'
August 26, 2023
Tags
waistline
Health Care
Market News
From
Benzinga
Republican Congressman George Santos Shed 92 Pounds With 'Miracle' Weight Loss Drug Ozempic: Report
August 25, 2023
Tags
Politics
Novo Nordisl
weightloss
From
Benzinga
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
August 25, 2023
Tickers
NVO
Tags
Market News
wegovy
General
From
Benzinga
Fake Ozempic Injections Circulate Social Media Amid Global Shortage: 'Felt Like I Was Going To Die'
August 21, 2023
Tags
Benzinga
weightloss
Diabetes
From
Benzinga
Kim Kardashian Faces Ozempic Accusations Over Dramatic Weight Loss
August 19, 2023
Tags
News
Ozempic
General
From
Benzinga
Former Playboy Model Jenna Jameson Denies Using Weight Loss Drug Ozempic: 'Just Minding My Health'
August 15, 2023
Tags
General
Media
Ozempic
From
Benzinga
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
WW International Inc
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
'Welcome To Crappie Lake' Stars Luann De Lesseps, Sonja Morgan Refute Ozempic Use: 'Are You Trying To Give Us A Hint?'
August 09, 2023
Tags
General
Ozempic
Biotech
From
Benzinga
Keke Palmer Criticizes 'Miracle' Weightloss Drug Ozempic Users: 'Folks With Diabetes Ain't Able To Get It'
August 02, 2023
Tags
Keke Palmer
Health Care
Market News
From
Benzinga
Elon Musk, Mark Zuckerberg, Jeff Bezos Shine Spotlight On Body Image Issues, Ozempic Craze Intensifies
August 02, 2023
Tags
Weight/based discrimination
Health Care
Market News
From
Benzinga
'Real Housewives' Star Jennifer Pedranti Backs Emily Simpson For Using 'Miracle' Weightloss Drug Ozempic, 'People Are Very Judgmental'
July 31, 2023
Tags
Emily Simpson
Media
weightloss
From
Benzinga
Emily Simpson Used 'Miracle' Drug Ozempic, Popularized By Kim Kardashian And Elon Musk, To Kickstart Weight-Loss Journey
July 27, 2023
Tags
Market News
Health Care
Benzinga
From
Benzinga
Expert Warns 'Miracle' Weight Loss Drug Ozempic Might Require Lifelong Use: 'Are You Prepared...?'
July 27, 2023
Tags
Health Care
Market News
wegovy
From
Benzinga
Teresa Giudice Under Fire From Fans Over Ozempic And Photoshop Claims: 'Please Be Real'
July 26, 2023
Tags
Market News
Health Care
wegovy
From
Benzinga
Novo Nordisk's Ozempic And Wegovy Under Scrutiny Amid Reports Of 'Stomach Paralysis'
July 25, 2023
Tickers
NVO
Tags
Short Sellers
Market News
wegovy
From
Benzinga
Shortage Of Elon Musk-Popularized 'Miracle' Weight-Loss Drug Puts Diabetic Patients In Peril, Regulator Warns
July 18, 2023
Tags
General
News
Biotech
From
Benzinga
Lisa Marie Presley's Autopsy Prompts Expert To Warn About 'Miracle' Weight Loss Drug Ozempic: 'Nobody's Talking About This'
July 16, 2023
Tags
Weight Loss
Benzinga
Diabetes
From
Benzinga
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Biotech and Pharmaceuticals
Science
Novo Nordisk A/S
From
CNBC.com News
Amy Schumer Says 'Felt So Sick' After Using Weight Loss Drug: 'Everyone's Lying...Shut The F**k Up. You Are On Ozempic'
July 13, 2023
Tags
Media
Diabetes
Health Care
From
Benzinga
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
July 13, 2023
Tags
Health & Science
Pharmaceuticals
Companies
From
CNBC.com News
Raven-Symoné Criticizes Hollywood's Misuse Of Ozempic For 'Glamazon' Purposes: 'Save Some Medication For The People That Actually Need It'
July 13, 2023
Tags
Health Care
Entertainment
Media
From
Benzinga
'Ozempic Butt:' TikTok User Says 'Nothing To Brag About' After Popular Weight Loss Drug Leaves Her With Saggy Skin
July 13, 2023
Tags
Health Care
Entertainment
Diabetes
From
Benzinga
'Miracle' Weight Loss Durg Ozempic's Has A Counterfeit In The Market – But It Has 'Life-Threatening' Consequences, Swiss Regulator Warns
July 12, 2023
Tags
wegovy
Swissmedic
Market News
From
Benzinga
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
July 11, 2023
Tickers
AMGN
LLY
NVO
PFE
Tags
Weight Loss
Novo Nordisk
Benzinga
From
Benzinga
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
Tags
Diabetes
Pfizer Inc
Law and Regulation
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.